On December 17, 2024, Portage Biotech Inc. announced a Letter of Intent with Immunova, LLC to negotiate an agreement for Immunova to acquire iOx Therapeutics, Ltd., a subsidiary of Portage.
AI Assistant
ALPHA COMPUTE CORP
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.